Adverse prognosis of incidentally detected ambulatory atrial fibrillation

Asymptomatic persistent atrial fibrillation and outcome: Results of the RACE study

(2014) Michiel Rienstra et al.   HEART RHYTHM

Atrial fibrillation patients do not benefit from acetylsalicylic acid

(2013) S. Sjalander et al.   EUROPACE

iPhone ECG application for community screening to detect silent atrial fibrillation: A novel technology to prevent stroke

(2013) Jerrett K. Lau et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: The Belgrade Atrial Fibrillation Study

(2013) Tatjana S. Potpara et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Adelaide Stroke Incidence Study

(2013) James M. Leyden et al.   STROKE

Screening to identify unknown atrial fibrillation

(2013) Nicole Lowres et al.   THROMBOSIS AND HAEMOSTASIS

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke

(2012) Bishoy Deif et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation

(2012) Cynthia A. Jackevicius   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Subclinical Atrial Fibrillation and the Risk of Stroke

(2012) Jeff S. Healey et al.   NEW ENGLAND JOURNAL OF MEDICINE

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

(2012) Christian Torp-Pedersen et al.   THROMBOSIS AND HAEMOSTASIS

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

(2011) Valentin Fuster et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study

(2011) Amitava Banerjee et al.   THROMBOSIS AND HAEMOSTASIS

Enhanced Detection of Paroxysmal Atrial Fibrillation by Early and Prolonged Continuous Holter Monitoring in Patients With Cerebral Ischemia Presenting in Sinus Rhythm

(2010) Raoul Stahrenberg et al.   STROKE

Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation

(2010) Caroline Medi et al.   STROKE

Stroke Associated with Atrial Fibrillation – Incidence and Early Outcomes in the North Dublin Population Stroke Study

(2009) Niamh Hannon et al.   CEREBROVASCULAR DISEASES

The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk

(2009) Taya V. Glotzer et al.   Circulation-Arrhythmia and Electrophysiology

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE